ECSP045071A - CYCLLOXYGENASA-2 INHIBITOR COMBINATION / HISTONA DEACETILATE INHIBITOR - Google Patents

CYCLLOXYGENASA-2 INHIBITOR COMBINATION / HISTONA DEACETILATE INHIBITOR

Info

Publication number
ECSP045071A
ECSP045071A ECSP045071A ECSP045071A EC SP045071 A ECSP045071 A EC SP045071A EC SP045071 A ECSP045071 A EC SP045071A EC SP045071 A ECSP045071 A EC SP045071A
Authority
EC
Ecuador
Prior art keywords
inhibitor
combination
deacetilate
cyclloxygenasa
histona
Prior art date
Application number
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP045071 priority Critical patent/ECSP045071A/en
Publication of ECSP045071A publication Critical patent/ECSP045071A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a una combinación que comprende (a) un inhibidor de ciclooxigenasa-2 ("inhibidor de COX-2") y (b) un inhibidor de desacetilasa de histona ("HDAI") para uso simultáneo, concurrente, separado o secuencial, especialmente para utilizarse en el tratamiento de lesiones colon pre-malignas o un cáncer de colon u otras malignidades en un mamífero, particularmente un ser humano. La invención también se refiere a composiciones farmacéuticas que comprenden dicha combinación y a un método para tratar lesiones de colon pre-malignas (por ejemplo, pólipos) y cáncer de colon, así como otras malignidades, en un mamífero, particularmente un ser humano, con dicha combinación. La presente invención además también se refiere a un paquete o producto comercial que comprende dicha combinación.The invention relates to a combination comprising (a) a cyclooxygenase-2 inhibitor ("COX-2 inhibitor") and (b) a histone deacetylase inhibitor ("HDAI") for simultaneous, concurrent, separate or sequential, especially for use in the treatment of pre-malignant colon lesions or colon cancer or other malignancies in a mammal, particularly a human being. The invention also relates to pharmaceutical compositions comprising said combination and to a method for treating pre-malignant colon lesions (eg polyps) and colon cancer, as well as other malignancies, in a mammal, particularly a human being, with said combination. The present invention also further relates to a commercial package or product comprising said combination.

ECSP045071 2004-04-21 2004-04-21 CYCLLOXYGENASA-2 INHIBITOR COMBINATION / HISTONA DEACETILATE INHIBITOR ECSP045071A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP045071 ECSP045071A (en) 2004-04-21 2004-04-21 CYCLLOXYGENASA-2 INHIBITOR COMBINATION / HISTONA DEACETILATE INHIBITOR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP045071 ECSP045071A (en) 2004-04-21 2004-04-21 CYCLLOXYGENASA-2 INHIBITOR COMBINATION / HISTONA DEACETILATE INHIBITOR

Publications (1)

Publication Number Publication Date
ECSP045071A true ECSP045071A (en) 2004-05-28

Family

ID=40435095

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP045071 ECSP045071A (en) 2004-04-21 2004-04-21 CYCLLOXYGENASA-2 INHIBITOR COMBINATION / HISTONA DEACETILATE INHIBITOR

Country Status (1)

Country Link
EC (1) ECSP045071A (en)

Similar Documents

Publication Publication Date Title
ATE352319T1 (en) COMBINATION CYCLOOXYGENASE-2 INHIBITOR/HISTONE DEACETYLASE INHIBITOR
MXPA05012464A (en) Combination of histone deacetylase inhibitors with chemotherapeutic agents.
CR8163A (en) PHARMACEUTICAL COMPOSITION CONTAINING A HISTONE DEACETILASE INHIBITOR
ECSP099483A (en) COMBINATION OF A HISTONE DEACETILASE INHIBITOR AND AN ANTIMETABOLITE
AR109605A2 (en) METHOD FOR TREATING PERIPHERAL VASCULAR DISEASES, COMPOSITION AND USE
CY1121398T1 (en) COMBINATION OF BREAKFAST AND BENZOLE PEROXIDE FOR THE TREATMENT OF ACNE DAMAGES
UY31067A1 (en) 5-LIPOXYGENASE ACTIVATING PROTEIN INHIBITORS (FLAP)
AR054566A1 (en) TREATMENT OF THE TUMORS THAT EXPRESS THE HER
AR059066A1 (en) COMBINATIONS OF THE ANGIOPOYETINE INHIBITOR -2 (ANG2) AND THE VASCULAR ENDOTELIAL GROWTH FACTOR INHIBITOR (VEGF)
NO20083780L (en) Topical composition comprising an antibacterial substance
BRPI0413363A (en) dosage forms providing controlled release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors
BRPI0809164B8 (en) COMPOSITION FOR TOPICAL ADMINISTRATION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPOSITION
CR10566A (en) APPROPRIATE HETEROCICLICAL COMPOUNDS FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LEVEL OF LIPIDS
EA201690265A2 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED ACYLANILIDES
AR029763A1 (en) USE OF A COMBINATION OF AN NSAID AND AN EGFR QUINASA INHIBITOR FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OR INHIBITION OF COLONIC POLYPS AND COLORECTAL CANCER, PHARMACEUTICAL COMPOSITION AND MEDICINAL PRODUCT
CL2007001724A1 (en) USE OF A STROGEN FOR THE TREATMENT OF DISEASES, CONDITIONS OR SYMPTOMS ASSOCIATED WITH DEFICIENT LEVELS OF STROGENS IN A WOMAN; PHARMACEUTICAL COMPOSITION THAT INCLUDES DAILY DOSAGE UNITS OF ESTRADIOL HEMIDRATE> 0.75 AND 1
CL2009000727A1 (en) Substituted n-hydroxy-3-phenylprop-2-enmide and n-hydroxy-3-phenylpropanamide derivative compounds; deacetylase enzyme inhibitors; its pharmaceutical composition; Useful in the treatment of cancer, tumors, psoriasis, Alzheimer's, among others.
WO2006087759A3 (en) Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field
AR066778A1 (en) COMBINED THERAPY FOR THE TREATMENT OF CANCER THAT INCLUDES VINFLUNINA AND TRASTUZUMAB
MX2007000117A (en) A COMBINATION COMPOSITION.
ES2124983T3 (en) USE OF A SUBSTANCE P ANTAGONIST FOR THE TREATMENT OF RED SKIN STAINS OF NEUROGENOUS ORIGIN.
PA8571901A1 (en) NEW PHARMACEUTICAL COMPOSITION
BRPI0507482A (en) combination of (a) a dna topoisomerase inhibitor and (b) a iap inhibitor
ES2723778T3 (en) Therapy directed at cancer stem cells and against drug-resistant cancer
WO2008082646A3 (en) Histone deacetylase inhibitors, combination therapies and methods of use